Breaking News Instant updates and real-time market news.

2020-04-29 09:25:00 ARWR Arrowhead $37.18 / -2.29 (-5.80%) , ALNY Alnylam $137.26 / -5.3 (-3.72%) … 09:25 04/29/20 04/29 09:25 04/29/20 09:25	Jefferies biotech analyst to hold an analyst/industry conference call Biotech Analyst Raycroft, along with Dr. Kyle Hogarth of the Alpha One Antitrypsin Deficiency Clinical Resource Center at the University of Chicago, discuss the current state of A1ATD therapies in development on an Analyst/Industry conference call to be held on April 29 at 10 am. ARWR Arrowhead $37.18 / -2.29 (-5.80%) ALNY Alnylam $137.26 / -5.3 (-3.72%) DRNA Dicerna $21.10 / -0.9 (-4.09%) VRTX Vertex Pharmaceuticals $257.10 / -11.27 (-4.20%)	29 Apr 29 Apr 06 May 06 May 06 May 07 May
ARWR ALNY DRNA VRTX ARWR Arrowhead $37.18 / -2.29 (-5.80%) 04/15/20 Cantor Fitzgerald Arrowhead pullback creates attractive entry point, says Cantor Fitzgerald 04/15/20 Cantor Fitzgerald Arrowhead upgraded to Overweight from Neutral at Cantor Fitzgerald 03/24/20 SVB Leerink Arrowhead upgraded to Market Perform at SVB Leerink on more balanced risk/reward 03/24/20 SVB Leerink Arrowhead upgraded to Market Perform from Underperform at SVB Leerink ALNY Alnylam $137.26 / -5.3 (-3.72%) 04/24/20 Evercore ISI Alnylam assumed with an Outperform at Evercore ISI 04/14/20 Cantor Fitzgerald Alnylam price target raised to $202 from $195 at Cantor Fitzgerald 04/14/20 Nomura Alnylam risks not absolved with Blackstone deal, says Nomura Instinet 04/13/20 Piper Sandler Alnylam price target lowered to $142 from $147 at Piper Sandler DRNA Dicerna $21.10 / -0.9 (-4.09%) 04/07/20 H.C. Wainwright Deal terms show Dicerna has 'upper hand,' says H.C. Wainwright 04/06/20 Piper Sandler Alnylam collaboration for AATD favors Dicerna, says Piper Sandler 03/19/20 Fly Intel: Top five analyst initiations 03/19/20 Berenberg Dicerna initiated with a Buy at Berenberg VRTX Vertex Pharmaceuticals $257.10 / -11.27 (-4.20%) 04/28/20 RBC Capital downgraded Vertex to Sector Perform on valuation 04/28/20 RBC Capital Vertex downgraded to Sector Perform from Outperform at RBC Capital 04/27/20 Piper Sandler Piper backs Overweight on Vertex after new Affinia partnership 03/27/20 Piper Sandler Vertex's 2020 business outlook not impacted by COVID-19, says Piper Sandler

2020-04-29 09:25:00

ARWR

Arrowhead

$37.18 / -2.29 (-5.80%)

, ALNY

Alnylam

$137.26 / -5.3 (-3.72%)

… 09:25

04/29/20

04/29

09:25

04/29/20

09:25

Jefferies biotech analyst to hold an analyst/industry conference call

Biotech Analyst Raycroft, along with Dr. Kyle Hogarth of the Alpha One Antitrypsin Deficiency Clinical Resource Center at the University of Chicago, discuss the current state of A1ATD therapies in development on an Analyst/Industry conference call to be held on April 29 at 10 am.

ARWR

Arrowhead

$37.18 / -2.29 (-5.80%)

ALNY

Alnylam

$137.26 / -5.3 (-3.72%)

DRNA

Dicerna

$21.10 / -0.9 (-4.09%)

VRTX

Vertex Pharmaceuticals

$257.10 / -11.27 (-4.20%)

29
Apr
29
Apr
06
May
06
May
06
May
07
May

ARWR
ALNY
DRNA
VRTX

ARWR Arrowhead

$37.18 / -2.29 (-5.80%)

04/15/20 Cantor Fitzgerald: Arrowhead pullback creates attractive entry point, says Cantor Fitzgerald

04/15/20 Cantor Fitzgerald: Arrowhead upgraded to Overweight from Neutral at Cantor Fitzgerald

03/24/20 SVB Leerink: Arrowhead upgraded to Market Perform at SVB Leerink on more balanced risk/reward

03/24/20 SVB Leerink: Arrowhead upgraded to Market Perform from Underperform at SVB Leerink

ALNY Alnylam

$137.26 / -5.3 (-3.72%)

04/24/20 Evercore ISI: Alnylam assumed with an Outperform at Evercore ISI

04/14/20 Cantor Fitzgerald: Alnylam price target raised to $202 from $195 at Cantor Fitzgerald

04/14/20 Nomura: Alnylam risks not absolved with Blackstone deal, says Nomura Instinet

04/13/20 Piper Sandler: Alnylam price target lowered to $142 from $147 at Piper Sandler

DRNA Dicerna

$21.10 / -0.9 (-4.09%)

04/07/20 H.C. Wainwright: Deal terms show Dicerna has 'upper hand,' says H.C. Wainwright

04/06/20 Piper Sandler: Alnylam collaboration for AATD favors Dicerna, says Piper Sandler

03/19/20: Fly Intel: Top five analyst initiations

03/19/20 Berenberg: Dicerna initiated with a Buy at Berenberg

VRTX Vertex Pharmaceuticals

$257.10 / -11.27 (-4.20%)

04/28/20: RBC Capital downgraded Vertex to Sector Perform on valuation

04/28/20 RBC Capital: Vertex downgraded to Sector Perform from Outperform at RBC Capital

04/27/20 Piper Sandler: Piper backs Overweight on Vertex after new Affinia partnership

03/27/20 Piper Sandler: Vertex's 2020 business outlook not impacted by COVID-19, says Piper Sandler

TODAY'S FREE FLY STORIES

Recommendations	Intercept price target lowered to $45 from $58 at Chardan » 05:03 03/01/21 03/01 05:03 03/01/21 05:03 ICPT Intercept $21.65 / -1.395 (-6.05%) Chardan analyst Michael… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly ICPT Intercept $21.65 / -1.395 (-6.05%) 02/25/21 Intercept: FDA interactions 'ongoing' regarding NISS for liver disorder 02/25/21 Intercept sees FY21 Ocaliva net sales $325M-$355M 02/22/21 Intercept Chief Medical Officer Jason Campagna to resign 02/17/21 Intercept appoints Lisa DeFrancesco to executive leadership team ICPT Intercept $21.65 / -1.395 (-6.05%) 02/23/21 H.C. Wainwright Intercept downgraded to Sell from Neutral at H.C. Wainwright 01/27/21 SVB Leerink SVB Leerink disagrees with RBC on conclusion of Intercept FDA review 01/19/21 Wedbush Intercept price target lowered to $106 from $116 at Wedbush 01/15/21 BofA Intercept downgraded to Underperform from Neutral at BofA ICPT Intercept $21.65 / -1.395 (-6.05%) 02/25/21 Intercept reports Q4 EPS ($1.58), consensus ($1.47) 11/09/20 Intercept narrows 2020 Ocaliva sales view $310-$320M from $300M-$320M 11/09/20 Intercept reports Q3 EPS ($2.01), consensus ($1.93) 18 Aug ICPT Intercept $21.65 / -1.395 (-6.05%) 10/08/20 FDA probes whether Intercept drug is tied to liver injury risk, STATNews reports ICPT Intercept $21.65 / -1.395 (-6.05%) 09/30/20 Before the Move: Watch Novo Nordisk, Bristol into AASLD abstract publication
Initiation	Telus International initiated with an Outperform at BMO Capital » 05:01 03/01/21 03/01 05:01 03/01/21 05:01 TIXT Telus International $29.09 / +0.09 (+0.31%) BMO Capital analyst Keith… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Syndicate On The Fly TIXT Telus International $29.09 / +0.09 (+0.31%) 02/23/21 Telus International, Google Cloud expand partnership 03 Feb TIXT Telus International $29.09 / +0.09 (+0.31%) 02/07/21 Opening Day: Sana raises largest-ever IPO for preclinical biotech
Recommendations	Moderna price target raised to $182 from $107 at Chardan » 05:00 03/01/21 03/01 05:00 03/01/21 05:00 MRNA Moderna $154.90 / +6.66 (+4.49%) Chardan analyst Geulah… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options MRNA Moderna $154.90 / +6.66 (+4.49%) 02/25/21 Moderna's chief medical officer Tal Zaks to leave company in late September 02/24/21 Moderna makes new capital investment to boost manufacturing capacity 02/24/21 Moderna ships mRNA-1273.351 to NIH for clinical study 02/24/21 Takeda provides update on Novavax, Moderna COVID-19 vaccine candidates in Japan MRNA Moderna $154.90 / +6.66 (+4.49%) 02/26/21 Barclays Moderna price target raised to $178 from $169 at Barclays 02/26/21 Brookline Moderna price target raised to $205 from $180 at Brookline 02/25/21 Piper Sandler Moderna transitioning into profitable company, says Piper Sandler 02/18/21 Jefferies Moderna price target raised to $180 from $150 at Jefferies MRNA Moderna $154.90 / +6.66 (+4.49%) 02/25/21 Moderna reports Q4 EPS (69c), consensus (35c) 02/24/21 Notable companies reporting before tomorrow's open 02/24/21 Notable companies reporting before tomorrow's open 10/29/20 Moderna reports Q3 EPS (59c), consensus (43c) 19 May MRNA Moderna $154.90 / +6.66 (+4.49%) 02/28/21 AstraZeneca sells stake in Moderna for over $1B, The Times reports 02/17/21 Moderna to supply EU with another 150M vaccine doses in 2021, FT reports 02/12/21 FDA tells Moderna it can boost vaccine supply in each vial, NY Times reports 02/11/21 White House secures deals for additional 200M COVID-19 vaccine doses, CNBC says MRNA Moderna $154.90 / +6.66 (+4.49%) 02/25/21 Fly Intel: Pre-market Movers 02/24/21 Fly Intel: After-Hours Movers 02/12/21 Fly Intel: Wall Street's top stories for Friday 02/12/21 Fly Intel: Wall Street's top stories at midday 03/16/21 31st Annual Healthcare Virtual Conference MRNA Moderna $154.90 / +6.66 (+4.49%) 02/01/21 Moderna call volume above normal and directionally bullish 01/25/21 Moderna call volume above normal and directionally bullish 12/17/20 Moderna call volume above normal and directionally bullish 11/27/20 Moderna call buyer realizes 22% same-day gains
Downgrade	Superdry downgraded to Hold from Buy at Jefferies » 04:59 03/01/21 03/01 04:59 03/01/21 04:59 SEPGY Superdry $0.00 / + (+0.00%) Jefferies analyst Andrew… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research SEPGY Superdry $0.00 / + (+0.00%) 12/07/20 RBC Capital Superdry downgraded to Sector Perform from Outperform at RBC Capital 12/07/20 RBC Capital Superdry downgraded to Sector Perform from Outperform at RBC Capital 11/26/20 Berenberg Superdry upgraded to Hold from Sell at Berenberg 10/21/20 Peel Hunt Superdry upgraded to Add from Hold at Peel Hunt
Initiation	Sana Biotechnology initiated with a Neutral at Goldman Sachs » 04:57 03/01/21 03/01 04:57 03/01/21 04:57 SANA Sana Biotechnology $30.73 / -1.4351 (-4.46%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Syndicate On The Fly 04 Feb SANA Sana Biotechnology $30.73 / -1.4351 (-4.46%) 02/07/21 Opening Day: Sana raises largest-ever IPO for preclinical biotech

Initiation	Five9 initiated with a Buy at Jefferies » 04:56 03/01/21 03/01 04:56 03/01/21 04:56 FIVN Five9 $185.19 / +3.8 (+2.09%) Jefferies analyst Samad… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events FIVN Five9 $185.19 / +3.8 (+2.09%) 02/22/21 Five9 jumps 11% to $185 after Q4 earnings beat 01/11/21 Five9 appoints Genefa Murphy PhD as new Chief Marketing Officer 12/16/20 Five9 enters strategic partnership with Conn3ct 12/10/20 Five9 and Deloitte Digital form alliance to accelerate growth in key regions FIVN Five9 $185.19 / +3.8 (+2.09%) 02/23/21 Wells Fargo Five9 price target raised to $210 from $200 at Wells Fargo 02/23/21 Truist Five9 price target raised to $215 from $165 at Truist 02/23/21 Northland Five9 price target raised to $200 from $163 at Northland 02/23/21 JPMorgan Five9 price target raised to $209 from $170 at JPMorgan FIVN Five9 $185.19 / +3.8 (+2.09%) 02/22/21 Five9 sees FY21 adjusted EPS 75c-79c, consensus 84c 02/22/21 Five9 sees Q1 adjusted EPS 12c-14c, consensus 12c 02/22/21 Five9 reports Q4 adjusted EPS 34c, consensus 23c 02/22/21 Notable companies reporting after market close FIVN Five9 $185.19 / +3.8 (+2.09%) 02/22/21 Fly Intel: After-Hours Movers 10/29/20 Fly Intel: After-Hours Movers 03/15/21 33rd Annual Roth Virtual Conference
Conference/Events	Wolfe Research energy analysts to hold an analyst/industry conference call » 04:55 03/01/21 03/01 04:55 03/01/21 04:55 Energy Analysts provide a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Conference/Events	e.l.f. Beauty participates in a conference call with JPMorgan » 04:55 03/01/21 03/01 04:55 03/01/21 04:55 ELF e.l.f. Beauty $25.70 / +0.505 (+2.00%) Beverage, Household &… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events ELF e.l.f. Beauty $25.70 / +0.505 (+2.00%) 02/23/21 GameStop announces resignation of CFO Jim Bell 02/03/21 e.l.f. Beauty CEO: We're really pleased with the quarter 01/22/21 e.l.f. Beauty CEO sells 34.6K shares of common stock 01/07/21 e.l.f. Beauty to replace Brooks Automation in the S&P 600 at open on January 7 ELF e.l.f. Beauty $25.70 / +0.505 (+2.00%) 02/04/21 e.l.f. Beauty price target raised to $30 from $25 at Truist 01/20/21 Piper Sandler e.l.f. Beauty downgraded to Neutral from Overweight at Piper Sandler 10/06/20 Piper Sandler Piper teen survey shows Snap, Amazon and Apple remain favorites 08/06/20 Truist e.l.f. Beauty price target raised to $25 from $20 at Truist ELF e.l.f. Beauty $25.70 / +0.505 (+2.00%) 02/03/21 e.l.f. Beauty raises FY21 EPS view to 63c-64c from 59c-63c 02/03/21 e.l.f. Beauty reports Q3 adjusted EPS 22c, consensus 24c 02/03/21 Notable companies reporting after market close 11/04/20 e.l.f. Beauty sees FY22-FY24 net sales up mid-high single digits ELF e.l.f. Beauty $25.70 / +0.505 (+2.00%) 02/03/21 Fly Intel: After-Hours Movers 12/30/20 Fly Intel: After-Hours Movers 11/04/20 Fly Intel: After-Hours Movers 10/06/20 Beyond Meat boosted by Piper Sandler teen survey results 11:00 Today e.l.f. Beauty - ELF
Conference/Events	Endesa management to meet virtually with JPMorgan » 04:55 03/01/21 03/01 04:55 03/01/21 04:55 ELEZF Endesa $0.00 / + (+0.00%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Events ELEZF Endesa $0.00 / + (+0.00%) 02/18/21 Credit Suisse Endesa double upgraded to Outperform from Underperform at Credit Suisse 02/18/21 Credit Suisse Endesa upgraded to Outperform from Underperform at Credit Suisse 11/23/20 RBC Capital Endesa price target raised to EUR 25 from EUR 20 at RBC Capital 10/28/20 JPMorgan Endesa price target raised to EUR 25.50 from EUR 24.50 at JPMorgan 00:00 Today Endesa
Conference/Events	Wedbush strategist to hold an analyst/industry conference call » 04:55 03/01/21 03/01 04:55 03/01/21 04:55 Chief Technology… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial

Conference/Events	Eaton to host virtual investor day » 04:55 03/01/21 03/01 04:55 03/01/21 04:55 ETN Eaton $130.33 / +0.22 (+0.17%) Virtual Investor Day to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events ETN Eaton $130.33 / +0.22 (+0.17%) 02/24/21 Eaton raises quarterly dividend 4% to 76c per share 02/01/21 Eaton to acquire Cobham Mission Systems for $2.83B 01/29/21 Eaton to acquire Tripp Lite for $1.65B 01/04/21 Eaton appoints Katrina Redmond as SVP, CIO ETN Eaton $130.33 / +0.22 (+0.17%) 02/16/21 Eaton participates in a conference call with Wolfe Research 02/16/21 Fly Intel: Top five analyst upgrades 02/16/21 HSBC Eaton upgraded to Buy from Hold at HSBC 02/16/21 HSBC Eaton upgraded to Buy from Hold at HSBC ETN Eaton $130.33 / +0.22 (+0.17%) 02/02/21 Eaton sees Q1 adjusted EPS $1.17-$1.27, consensus $1.05 02/02/21 Eaton sees FY21 adjusted EPS $5.40-$5.80, consensus $4.83 02/02/21 Eaton reports Q4 adjusted EPS $1.28, consensus $1.20 11/03/20 Eaton sees FY20 operating cash flow $2.8B-$3.0B ETN Eaton $130.33 / +0.22 (+0.17%) 12/19/20 Alphabet, Apple among Barron's 10 Top stocks for 2021, Barron's says 09:00 Today Eaton Corporation plc
General news	Federal Reserve Board Governor Lael Brainard Speech to be released at 09:05 04:55 03/01/21 03/01 04:55 03/01/21 04:55
General news	Atlanta Federal Reserve Bank President Raphael Bostic Speech to be released at 14:00 04:55 03/01/21 03/01 04:55 03/01/21 04:55
General news	New York Federal Reserve Bank President John Williams Speech to be released at 09:00 04:55 03/01/21 03/01 04:55 03/01/21 04:55
Conference/Events	Wedbush retail/hardlines analyst holds an analyst/industry conference call » 04:55 03/01/21 03/01 04:55 03/01/21 04:55 WOOF Petco $19.94 / -1.09 (-5.18%) Retail Hardlines Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Syndicate On The Fly Events Options WOOF Petco $19.94 / -1.09 (-5.18%) 02/08/21 Fly Intel: Top five analyst initiations 02/08/21 Evercore ISI Petco initiated with an Outperform at Evercore ISI 02/08/21 BofA Petco initiated with a Neutral at BofA 02/08/21 Citi Petco initiated with a Buy at Citi 14 Jan WOOF Petco $19.94 / -1.09 (-5.18%) 02/08/21 Target, Estee Lauder upgrades among today's top calls on Wall Street 01/17/21 Opening Day: Poshmark surges in debut, PetCo soars in return to market 01/10/21 Opening Day: Cullinan, Gracell surge in debut as SPAC craze continues 01/03/21 Opening Day: Six IPOs to watch in 2021 10:00 Today Retail--Hardlines WOOF Petco $19.94 / -1.09 (-5.18%) 01/21/21 Eighteen new option listings and one option delisting on January 21st

Conference/Events	JPMorgan transports/logistics analyst to hold analyst/industry conference call » 04:55 03/01/21 03/01 04:55 03/01/21 04:55 Transports &… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Conference/Events	Genius Sports participates in a conference call with Benchmark » 04:55 03/01/21 03/01 04:55 03/01/21 04:55 GENI Genius Sports $0.00 / + (+0.00%) Entertainment Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Events GENI Genius Sports $0.00 / + (+0.00%) 02/23/21 Benchmark dMY Technology II initiated with a Buy at Benchmark 12:00 Today Genius Sports - GENI
Conference/Events	Fluidra management to meet virtually with JPMorgan » 04:55 03/01/21 03/01 04:55 03/01/21 04:55 FLUIF Fluidra $0.00 / + (+0.00%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Events FLUIF Fluidra $0.00 / + (+0.00%) 02/18/21 Citi Fluidra price target raised to EUR 24.40 from EUR 20.40 at Citi 01/25/21 HSBC Fluidra upgraded to Buy from Hold at HSBC 01/21/21 Santander Fluidra downgraded to Hold from Buy at Santander 01/08/21 Berenberg Fluidra price target raised to EUR 22 from EUR 18 at Berenberg 00:00 Today Fluidra
Conference/Events	UBS technology analyst to hold lan analyst/industry conference call » 04:55 03/01/21 03/01 04:55 03/01/21 04:55 Technology Analyst Arcuri… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Conference/Events	Golden Star Resources to host conference call » 04:55 03/01/21 03/01 04:55 03/01/21 04:55 GSS Golden Star Resources $3.15 / -0.12 (-3.67%) Conference call to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events GSS Golden Star Resources $3.15 / -0.12 (-3.67%) 02/24/21 Golden Star Resources sees 2021 production 165-175k oz. 10/28/20 Golden Star Resources sees 2020 production 187-192koz 10/01/20 Royal Gold completes separation of Wassa, Prestea/Bogos stream agreements GSS Golden Star Resources $3.15 / -0.12 (-3.67%) 02/02/21 National Bank Golden Star Resources price target lowered to C$8 from C$8.25 at National Bank 09/11/20 National Bank Golden Star Resources price target raised to C$8.25 from C$8 at National Bank 09/08/20 Desjardins Golden Star Resources initiated with a Hold at Desjardins 07/30/20 National Bank Golden Star upgraded to Outperform from Sector Perform at National Bank GSS Golden Star Resources $3.15 / -0.12 (-3.67%) 02/24/21 Golden Star Resources reports Q4 adjusted EPS 11c, consensus 15c 10/28/20 Golden Star Resources reports Q3 adjusted EPS 17c, consensus 11c 09:00 Today Golden Star Resources - GSS

General news	3-Month Bill Auction to be released at 11:30 04:55 03/01/21 03/01 04:55 03/01/21 04:55
Conference/Events	Viatris to host virtual investor day » 04:55 03/01/21 03/01 04:55 03/01/21 04:55 VTRS Viatris $14.84 / -0.22 (-1.46%) Virtual Investor Day to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options VTRS Viatris $14.84 / -0.22 (-1.46%) 02/22/21 Viatris to initiate 11c per share quarterly dividend in May 01/28/21 FTC approves final order on Pfizer, Mylan deal with conditions 12/21/20 Mapi Pharma provides enrollment update on Phase III GA Depot trial 12/18/20 Viatris acquires 27,736 common shares VTRS Viatris $14.84 / -0.22 (-1.46%) 02/26/21 Wolfe Research Viatris downgraded to Peer Perform from Outperform at Wolfe Research 02/23/21 Barclays Viatris price target lowered to $20 from $26 at Barclays 01/06/21 RBC Capital Viatris named one of top stocks to own in 2021 by RBC Capital 01/05/21 Argus Viatris initiated with a Hold at Argus VTRS Viatris $14.84 / -0.22 (-1.46%) 02/22/21 Viatris sees FY21 revenue $17.2B-$17.8B, consensus $18.46B 08:30 Today Viatris Inc VTRS Viatris $14.84 / -0.22 (-1.46%) 02/19/21 Viatris call volume above normal and directionally bullish 02/08/21 Viatris put volume heavy and directionally bearish 01/14/21 Viatris call volume above normal and directionally bullish 12/31/20 Viatris call volume above normal and directionally bullish
General news	Construction Spending Month over Month to be reported at 10:00 » 04:55 03/01/21 03/01 04:55 03/01/21 04:55 January Construction… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Conference/Events	LeMaitre management to meet virtually with BTIG » 04:55 03/01/21 03/01 04:55 03/01/21 04:55 LMAT LeMaitre $51.68 / +4.24 (+8.94%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events LMAT LeMaitre $51.68 / +4.24 (+8.94%) 11/02/20 LeMaitre CEO sells 93K shares of common stock LMAT LeMaitre $51.68 / +4.24 (+8.94%) 02/26/21 Barrington LeMaitre price target raised to $49 from $47 at Barrington 02/12/21 Fly Intel: Top five analyst initiations 02/12/21 KeyBanc LeMaitre initiated with a Sector Weight at KeyBanc 02/11/21 KeyBanc LeMaitre initiated with a Sector Weight at KeyBanc LMAT LeMaitre $51.68 / +4.24 (+8.94%) 10/29/20 LeMaitre sees Q4 EPS 94c-$1.04, consensus 22c 10/29/20 LeMaitre reports Q3 EPS 37c, consensus 19c 00:00 Today LeMaitre
Hot Stocks	Cleveland-Cliffs to replace Eaton Vance in S&P 400 at open on 3/1 » 04:55 03/01/21 03/01 04:55 03/01/21 04:55 CLF Cleveland-Cliffs $13.36 / -1.05 (-7.29%) , EV Eaton Vance $73.09 / -0.78 (-1.06%) , MS Morgan Stanley $76.87 / -1.56 (-1.99%) Morgan Stanley (MS) is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options CLF EV MS CLF Cleveland-Cliffs $13.36 / -1.05 (-7.29%) 04:55 Today Cleveland-Cliffs to replace Eaton Vance in S&P 400 at open on 3/1 04:55 Today WSFS Financial to replace Cleveland-Cliffs in S&P 600 at open on 3/1 02/25/21 Cleveland-Cliffs on track to reach $150M synergy target by end of year 02/25/21 Cleveland-Cliffs: Active optimization process 'off to a great start' EV Eaton Vance $73.09 / -0.78 (-1.06%) 04:55 Today Cleveland-Cliffs to replace Eaton Vance in S&P 400 at open on 3/1 02/23/21 Cleveland-Cliffs to replace Eaton Vance in S&P 400 at open on 3/1 01/20/21 Morgan Stanley expects to close Eaton Vance deal no later than early in Q2 01/15/21 Eaton Vance reports consolidated AUM $583.1B on December 31 MS Morgan Stanley $76.87 / -1.56 (-1.99%) 04:55 Today Cleveland-Cliffs to replace Eaton Vance in S&P 400 at open on 3/1 02/23/21 Cleveland-Cliffs to replace Eaton Vance in S&P 400 at open on 3/1 02/01/21 Playstudios to go public through merger with Acies Acquisition 01/22/21 Morgan Stanley director sells 29K shares of common stock CLF EV MS CLF Cleveland-Cliffs $13.36 / -1.05 (-7.29%) 02/03/21 Credit Suisse U.S. Steel Industry upgraded to Overweight at Credit Suisse 01/26/21 GLJ Research Cleveland-Cliffs downgraded to Hold on 'emerging headwinds' at GLJ Research 01/26/21 GLJ Research Cleveland-Cliffs downgraded to Hold from Buy at GLJ Research 01/18/21 Exane BNP Paribas Cleveland-Cliffs upgraded to Outperform from Neutral at Exane BNP Paribas EV Eaton Vance $73.09 / -0.78 (-1.06%) 11/23/20 JPMorgan Eaton Vance downgraded to Neutral from Overweight at JPMorgan 11/11/20 Deutsche Bank Eaton Vance price target raised to $65 from $61 at Deutsche Bank 10/12/20 Gordon Haskett Voya Financial CEO 'fits the profile of a seller,' says Gordon Haskett 10/09/20 Keefe Bruyette Morgan Stanley paid 'full price' for Eaton Vance, says Keefe Bruyette MS Morgan Stanley $76.87 / -1.56 (-1.99%) 01/25/21 Credit Suisse Morgan Stanley price target raised to $84 from $74 at Credit Suisse 01/21/21 DA Davidson Morgan Stanley price target raised to $90 from $80 at DA Davidson 01/21/21 Barclays Morgan Stanley price target raised to $95 from $88 at Barclays 01/21/21 RBC Capital Morgan Stanley price target raised to $78 from $55 at RBC Capital CLF EV MS CLF Cleveland-Cliffs $13.36 / -1.05 (-7.29%) 02/25/21 Cleveland-Cliffs reports Q4 EPS 14c, consensus 22c 01/25/21 Cleveland-Cliffs sees Q4 revenues $2.2B-$2.4B, consensus $1.82B 10/23/20 Cleveland-Cliffs reports Q3 EPS (2c), consensus (10c) 09/28/20 Cleveland-Cliffs expects ArcelorMittal USA acquisition to be EPS accretive EV Eaton Vance $73.09 / -0.78 (-1.06%) 02/24/21 Eaton Vance reports Q4 adjusted EPS 94c, consensus 87c 11/24/20 Eaton Vance reports Q4 adjusted EPS 88c, consensus 86c 10/13/20 Fly Intel: What to watch in next round of big banks' earnings reports MS Morgan Stanley $76.87 / -1.56 (-1.99%) 01/20/21 Morgan Stanley reports Q4 EPS $1.81, consensus $1.27 01/19/21 Notable companies reporting before tomorrow's open 01/19/21 Notable companies reporting before tomorrow's open 01/18/21 Fly Intel: What to watch in next round of big banks' earnings reports 09 Feb EV MS EV Eaton Vance $73.09 / -0.78 (-1.06%) 12/17/20 JPMorgan lost out to Morgan Stanley on Eaton Vance, FT reports 10/10/20 Asset managers under pressure, AllianceBernstein 'is different,' Barron's says 10/10/20 Eaton Vance deal presages more M&A, Barron's says 10/09/20 JPMorgan CEO says could be 'quite interested' in right asset manager, FT reports MS Morgan Stanley $76.87 / -1.56 (-1.99%) 02/15/21 Morgan Stanley investing arm weighs adding Bitcoin to bets list, Bloomberg says 01/05/21 Oatly planning 2021 initial public offering, CNBC reports 12/31/20 M&A activity rebounded into year-end to finish 2020 down just 5%, FT says 12/22/20 Tech companies win as SEC permits direct IPOs for cash raise, Bloomberg says CLF EV MS CLF Cleveland-Cliffs $13.36 / -1.05 (-7.29%) 02/09/21 Fly Intel: Pre-market Movers 09/28/20 Fly Intel: Wall Street's top stories for Monday 09/28/20 Fly Intel: Wall Street's top stories at midday 09/28/20 Fly Intel: Pre-market Movers EV Eaton Vance $73.09 / -0.78 (-1.06%) 10/08/20 Fly Intel: Wall Street's top stories for Thursday 10/08/20 Fly Intel: Wall Street's top stories at midday 10/08/20 Fly Intel: Pre-market Movers MS Morgan Stanley $76.87 / -1.56 (-1.99%) 01/28/21 GameStop, AMC rally after-hours as Robinhood to allow 'limited buys' 01/20/21 Fly Intel: Wall Street's top stories for Wednesday 01/20/21 Fly Intel: Wall Street's top stories at midday 01/20/21 Fly Intel: Pre-market Movers 04/16/21 Morgan Stanley - MS 04/28/21 Cleveland-Cliffs Inc. 05/11/21 Cleveland-Cliffs CLF MS CLF Cleveland-Cliffs $13.36 / -1.05 (-7.29%) 02/23/21 Cleveland-Cliffs call volume above normal and directionally bullish 02/22/21 Cleveland-Cliffs call volume above normal and directionally bullish 02/04/21 Cleveland-Cliffs call volume above normal and directionally bullish 01/15/21 Cleveland-Cliffs call volume above normal and directionally bullish MS Morgan Stanley $76.87 / -1.56 (-1.99%) 02/16/21 Morgan Stanley call volume above normal and directionally bullish 01/29/21 Morgan Stanley put volume heavy and directionally bearish 01/15/21 Unusual call flow in option market yesterday 01/14/21 $1.3M call seller in Morgan Stanley opens two week position into earnings

Events

Earnings calls, analyst events, roadshows and more

ATNX
Today at 08:00

Athenex - ATNX Conference Calls
EVTC
Today at 08:00

Evertec - EVTC Conference Calls
MORF
Today at 08:00

Morphic Holding - MORF Conference Calls
AXSM
Today at 08:00

Axsome Therapeutics - AXSM Conference Calls
PRGO
Today at 08:00

Perrigo - PRGO Conference Calls
CDLX
Today at 08:00

Cardlytics - CDLX Conference Calls
THRM
Today at 08:00

Gentherm - THRM Conference Calls
ZLAB
Today at 08:00

Zai Lab - ZLAB Conference Calls
CWEN
Today at 08:00

Clearway Energy - CWEN Conference Calls
ACIA
Today at 08:00

Acacia Communications, Inc. Firm Sponsored Meetings

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB $32.00-34.00 31M Shares
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans $17.00-19.00 16.667M Shares AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC $27.97 2.5M Shares
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Jefferies biotech analyst to hold an analyst/industry conference call

TODAY'S FREE FLY STORIES

Get Full Fly Access